BPTS Biophytis SA

UNITED STATES SECURITIES 

AND EXCHANGE COMMISSION 

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER 

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Date of report: April 18, 2023

Commission File Number: 001-38974

BIOPHYTIS S.A.

(Translation of registrant’s name into English)

Stanislas Veillet
Biophytis S.A. 

Sorbonne University—BC 9, Bâtiment A 4ème étage 

4 place Jussieu 

75005 Paris, France 

+33 1 44 27 23 00 

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

x Form 20-F   ¨  Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

On April 18, 2023, Biophytis S.A. issued a press release announcing 2022 Financial Results and 2023 Perspectives. A copy of the press release is attached as Exhibit 99.1 to this Form 6-K.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Biophytis (NASDAQ:BPTS)
Historical Stock Chart
From Mar 2025 to Apr 2025

Biophytis (NASDAQ:BPTS)
Historical Stock Chart
From Apr 2024 to Apr 2025